(Q43432793)

English

Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Theodore Friedmann

2

object named as

Theodore Friedmann

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ghiabe-Henri Guibinga

1

object named as

Ghiabe H Guibinga

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

645-651

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Baculovirus display strategies: Emerging tools for eukaryotic libraries and gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Controlling the complement system in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Complement-protected amphotropic retroviruses from murine packaging cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Expanding baculovirus surface display. Modification of the native coat protein gp64 of Autographa californica NPV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Enhanced gene delivery by avidin-displaying baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Separable mechanisms of attachment and cell uptake during retrovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.002

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMTHE.2004.12.002

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43432793&oldid=1988796697"